The SLC39A7 gene helps move zinc inside cells, which supports cell signaling, growth, and the development of immune cells. This gene plays an important role in helping B cells mature so your body can make antibodies to fight infection. If it does not work properly, zinc balance inside cells can be disturbed, and some people develop an inherited immune condition with very low antibody levels, frequent infections, and poor growth. Variants in both copies of the SLC39A7 gene can be enough to confirm this diagnosis.
What is a gene?
A gene is a stretch of DNA with instructions that your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
SLC39A7Gene function
What if the gene works
The SLC39A7 gene helps move zinc from cell storage areas to where cells need it. This supports cell growth, protein processing, and normal immune system development.
Risk
What if the gene does not work
When both copies of the SLC39A7 gene do not work properly, B cells may not mature, causing very low antibody levels and repeated infections. Milder or more severe variants can influence how early symptoms appear and how severe they become.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic or loss-of-function variant in the SLC39A7 gene. The SLC39A7 gene is being studied as a possible drug target and biomarker in some cancers, but this has not led to established gene-specific care.
Conditions associated with SLC39A7
Gene function
What if the gene works
Many everyday cell tasks depend on zinc being in the right place at the right time. The SLC39A7 gene helps move zinc inside cells, especially from storage spaces into the cell fluid where it can be used. This steady flow supports normal cell activity across many tissues.
The SLC39A7 gene helps release zinc from storage areas inside the cell into the main cell fluid. This makes zinc available where cells need it for routine work.
Zinc acts like a small messenger in many cell pathways. By controlling zinc flow, this gene helps cells send and respond to signals in a balanced way.
Many proteins and enzymes need zinc to do their jobs. Keeping zinc available in the right place helps cells grow, maintain themselves, and carry out normal repair.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC39A7 gene can change the ZIP7 protein so it is unstable, misshapen, stuck in the wrong part of the cell, or less able to move zinc across internal membranes. In practical terms, how SLC39A7 gene variants affect cells often depends on how much transporter activity remains. Milder variants may leave partial function, while more severe loss-of-function variants can leave little or none, which may contribute to earlier or more marked immune deficiency.
How variants are linked to conditions
Pathogenic variants in the SLC39A7 gene cause a rare inherited immune condition called agammaglobulinemia with absent B cells. People with this diagnosis usually have very low antibody levels and may develop repeated infections, often starting in infancy or childhood. Among SLC39A7 gene variants linked to conditions, this immune deficiency is the main well-established association.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SLC39A7 gene. For many living with a disease-causing change in SLC39A7, risk is mainly tied to the genetic change itself rather than lifestyle or environmental factors.
Inheritance of SLC39A7 variants
For families looking into SLC39A7 inheritance, disease causing variants in the SLC39A7 gene are inherited in an autosomal recessive pattern. This means a person usually develops the related condition only when they inherit two nonworking copies, one from each parent. Parents who each carry one variant are typically unaffected carriers. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants.
What does my SLC39A7 result mean for my family?
For families affected by SLC39A7-related immune deficiency, the pattern is usually recessive, which means close relatives may be healthy carriers without knowing it. Brothers and sisters may also be affected or be carriers, and other relatives on both sides of the family could carry the same gene change. Family testing can help clarify who else may be at risk of having an affected child.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SLC39A7 gene is done with genetic testing, usually on a blood sample or cheek swab. For people looking into how to test for SLC39A7 variants, the lab reads the gene’s DNA code and compares it with the usual sequence to see whether a variant is present.
When should I consider getting a genetic test?
Consider testing the SLC39A7 gene if someone has repeated serious infections, very low antibody levels, or missing infection-fighting B cells, especially starting in infancy or childhood. Testing may also help when this pattern runs in the family or when doctors are checking for agammaglobulinemia, a condition where the body cannot make enough antibodies.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, or used by the body, so the same treatment may work well for one person but less well for another. This is a common reason people can differ in benefit or in how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It looks at connections between genes and drugs to better understand why the same treatment may work differently in different people. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC39A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about side effects, how well a treatment is working, or other health concerns are best discussed with your doctor.